Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sterile product development company InnoPharma has commercially launched Cosyntropin Injection, 0.25mg/vial in the US.
Subscribe to our email newsletter
Cosyntropin injection, 0.25mg/vial available in single-use vials is generic equivalent of Cortrosyn injection.
Cosyntropin injection is indicated for use as a diagnostic agent to detect patients with suspected adrenocortical insufficiency.
InnoPharma develops complex generic and innovative specialty pharmaceutical products in injectable and ophthalmic dosage forms.